Christopher Lee, MD

Articles by Christopher Lee, MD

Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancer

ByChristopher Lee, MD

October 2nd 2025

Latest Updated Articles

Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancer
October 2nd 2025

Trending on Urology Times

Alternative BCG strains may help address ongoing supply challenges in NMIBC

Doublet or triplet? Urologists weighs in on mCSPC options

Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

Phase 3 trial of padeliporfin VTP completes treatment in LG-UTUC